DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (AN...
FDA Device Recall #Z-2627-2017 — Class III — May 22, 2017
Recall Summary
| Recall Number | Z-2627-2017 |
| Classification | Class III — Low risk |
| Date Initiated | May 22, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Euro Diagnostica AB |
| Location | Malmo, N/A |
| Product Type | Devices |
| Quantity | 501 units |
Product Description
DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of ANAs in human serum or EDTA plasma. It detects ANAs against Sm, Sm/RNP, Ro (SS-A), La (SS-B), Scl-70, Jo-1, dsDNA, histone and centromere antigens.
Reason for Recall
FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the kit box stating the original expiration date, the packaging did not display the correct expiration date.
Distribution Pattern
MN, TX, NE, PA, Spain, Egypt, Pakistan, Nepal, Canada
Lot / Code Information
TS 3577
Other Recalls from Euro Diagnostica AB
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0306-2018 | Class II | Euro Diagnostica DIASTAT ANA (anti-nuclear anti... | Feb 14, 2017 |
| Z-2919-2018 | Class III | is a quantitative/qualitative enzyme-linked imm... | Oct 21, 2016 |
| Z-2920-2018 | Class III | is a quantitative/qualitative enzyme-linked imm... | Oct 21, 2016 |
| Z-2922-2018 | Class III | is a qualitative indirect enzyme immunoassay en... | Oct 21, 2016 |
| Z-2921-2018 | Class III | is a quantitative/qualitative enzyme-linked imm... | Oct 21, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.